Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

842

Citations

21

References

2016

Year

Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani, Seema Singhal, Ajai Chari, Nizar J. Bahlis, Andrew R. Belch, Amrita Krishnan, Robert Vescio, María‐Victoria Mateos,

Hematological MalignancyOncologyDaratumumab MonotherapyImmunologyClinical TrialsImmune Checkpoint InhibitorImmunotherapyMedicineTreatment-refractory Multiple Myeloma

References

	Year	Citations

Page 1

Page 1